1. Successful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline.
- Author
-
Graber E and Kay CR
- Subjects
- Administration, Oral, Adult, Biopsy, Cheek, Cheilitis diagnosis, Cheilitis immunology, Cheilitis pathology, Crohn Disease immunology, Dermatitis diagnosis, Dermatitis immunology, Dermatitis pathology, Female, Humans, Skin pathology, Treatment Outcome, Anti-Bacterial Agents administration & dosage, Cheilitis drug therapy, Crohn Disease complications, Dermatitis drug therapy, Tetracyclines administration & dosage
- Abstract
Broad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic resistance and gut dysbiosis associated with broad spectrum tetracyclines emphasizes the importance and responsibility of antibiotic stewardship. Narrow spectrum antibiotics have become increasingly important therapies to slow the progression of resistance as well as decrease negative side effect profiles, particularly those associated with broad spectrum tetracyclines. This case shows the successful treatment of periorificial dermatitis with a novel, narrow spectrum tetracycline, sarecycline, in a patient with underlying Crohn’s. J Drugs Dermatol. 2021;20(1):98-100. doi:10.36849/JDD.5678.
- Published
- 2021
- Full Text
- View/download PDF